The effects of vitamin D
2 (VD
2) on hypocalcemia were studied in 54 hypocalcemic patients (29 males and 25 females) on chronic hemodialysis. Calcium lactate (3g/day) or VD
2 (10, 000 IU/day, 50, 000 IU/day and 80, 000 IU/day) were administered for 4 months in order to correct the hypocalcemia. Serum calcium, phosphate and alkaline phosphatase levels were measured and the effects of VD
2 on these parameters of calcium metabolism were followed. 1) Calcium lactate or 10, 000 IU/day of VD
2 were not effective for the correction of hypocalcemia, while 50, 000-80, 000 IU/day of VD
2 were effective. The effects of VD
2 on serum calcium concentrations were dose-dependent, and the normalization of serum calcium concentrations was achieved more rapidly with higher doses of VD
2. However, in the group treated with 80, 000 IU/day of VD
2, many patients developed hypercalcemia, but in the group treated with 50, 000 IU/day of VD
2, only a few patients did it. From these results, suitable dose (initial and maintenance doses) of VD
2 in dialysed patients would be 50, 000 IU/day. 2) When the responder group (normal serum calcium levels after 4 months of treatment with 50, 000 IU/ day of VD
2) and the non-responder group serum calcium levels lower than 4.2 mEq/liter on the same condition) were compared, the durations of dialysis were significantly shorter in the former than those in the latter. This fact may suggest that the effects of VD
2 administration on hypocalcemia in dialysed patients are partly dependent on the residual renal function concerning the conversion of 25-OH-D
3 into 1, 25 (OH)
2D
3.
View full abstract